Simon De Belder - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Eye and Vision (London, England)|April 7, 2016

Where does selective laser trabeculoplasty stand now? A reviewMyrjam De Keyser, Maya De Belder, Simon De Belder, et al.

Pharmacy (Basel, Switzerland)|December 15, 2018

Patient Perceptions of Electronic Prescriptions in Belgium: An Exploratory Policy AnalysisLaura Suykerbuyk, Marieke Robbrecht, Simon De Belder, et al.

Clinical Therapeutics|April 29, 2021

Effect of Statin Therapy on the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients With Hyperlipidemia: A Proof-of-concept Observational StudyKaren Claesen, Joachim C Mertens, Shahir Basir, et al.

Journal of Thrombosis and Haemostasis : JTH|February 5, 2023

Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individualsKaren Claesen, Yani Sim, Shahir Basir, et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 16, 2016

Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissectionsJosephina A N Meester, Geert Vandeweyer, Isabel Pintelon, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Eye and Vision (London, England)|April 7, 2016

Where does selective laser trabeculoplasty stand now? A reviewMyrjam De Keyser, Maya De Belder, Simon De Belder, et al.

Pharmacy (Basel, Switzerland)|December 15, 2018

Patient Perceptions of Electronic Prescriptions in Belgium: An Exploratory Policy AnalysisLaura Suykerbuyk, Marieke Robbrecht, Simon De Belder, et al.

Clinical Therapeutics|April 29, 2021

Effect of Statin Therapy on the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients With Hyperlipidemia: A Proof-of-concept Observational StudyKaren Claesen, Joachim C Mertens, Shahir Basir, et al.

Journal of Thrombosis and Haemostasis : JTH|February 5, 2023

Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individualsKaren Claesen, Yani Sim, Shahir Basir, et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 16, 2016

Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissectionsJosephina A N Meester, Geert Vandeweyer, Isabel Pintelon, et al.

Pageof 1